The number of homing tumor cells in tumor-bearing lungs decreased significantly after the pre-infusion of CEBPδ-siRNA-treated liver CD45+ cells derived from tumor-bearing mice compared to control siRNA-treated cells (Fig. 4b). This evidence concerns the gene CEBPD and neoplasm.